Respiratory Function
Conditions
Keywords
spirometry, TCAI (Cognitive-induced trance)
Brief summary
The goal of this Prospective, monocentric, non-randomized, open-label study aimed at evaluating the variation of FEV1 during a state of self-induced cognitive trance participant population: Person with expertise in the practice of TCAI can be inclued. (at least 6 months, in order to be able to control the depth of the trance and to have a motor control allowing the realization of a spirometry) The main question: Study the significant variation of FEV1 before, during, or after the state of self-induced cognitive trance
Detailed description
Primary objective : Study the significant variation of FEV1 before, during, or after the state of self-induced cognitive trance judgment criteria: Significant variations in: PEF PEF25 PEF50 PEF75 FVC Inspiratory capacity, SpO2 Respiratory rate before, during, or after the self-induced cognitive trance state Evolution of the feeling of self-efficacy, assessed by questionnaire
Interventions
DIAGNOSTIC_TESTspirometry
Inclusion visit: Performing spirometry. Visit 2 (in the month following the inclusion visit): Induction of a self-induced cognitive trance by the participant; performance of spirometry before, during the trance then 8 minutes after the end of the trance Actimetry during trance
Sponsors
Centre Hospitalier Metropole Savoie
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE
Masking description
Person with expertise in the practice of TCAI. (at least 6 months, in order to be able to control the depth of the trance and to have a motor control allowing the realization of a spirometry)
Intervention model description
Prospective, monocentric, non-randomized, open-label study.
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Person over 18 years old * Person with expertise in the practice of TCAI. (at least 6 months, in order to be able to control the depth of the trance and to have a motor control allowing the realization of a spirometry) * Person affiliated with social security or beneficiary of such a scheme. * Person having given, in writing, their free and informed consent to participate in the study
Exclusion criteria
* Person deprived of liberty by judicial or administrative decision, person subject to a measure of legal protection. * Exclusion period for other studies * Person likely, according to the investigator's assessment, not to be cooperative or respectful of the obligations inherent in participation in the study * Person with a psychiatric, neurological or cardiovascular disease. * Person with a chronic respiratory disease, for example: asthma, COPD, interstitial lung disease, bronchial dilation, cystic fibrosis, * Person with a history of exercise-induced bronchospasm. * Person taking inhaled treatments (corticotherapy, bronchodilators, anticholinergics) * Pregnant woman (declarative).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| FEV during a state of self-induced cognitive trance | 3 month | variation of forced exhaled volume in one second between pre and post phase of cognitive transe |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| DEM25/50/75 during a state of self-induced cognitive trance | 3 month | variation of DEM25/50/75 between pre, per and post phase of cognitive transe |
| inspiratory capacity during a state of self-induced cognitive trance | 3 month | variation of inspiratory capacity between pre, per and post phase of cognitive transe |
| PEF during a state of self-induced cognitive trance | 3 month | variation of PEF between pre, per and post phase of cognitive transe |
| SpO2 during a state of self-induced cognitive trance | 3 month | variation of SpO2 between pre, per and post phase of cognitive transe |
| FVC during a state of self-induced cognitive trance | 3 month | variation of FVC between pre, per and post phase of cognitive transe |
| respiratory rate during a state of self-induced cognitive trance | 3 month | variation of respiratory rate between pre, per and post phase of cognitive transe |
Countries
France
Outcome results
None listed